Newsroom | 9980 results

LAS VEGAS--(BUSINESS WIRE)--Molina Healthcare of Nevada invests over $400,000 in support of enhanced behavioral health services and access to care across the state....

ATLANTA--(BUSINESS WIRE)--Perimeter Roofing is proud to announce the donation and installation of a new roof for The Blake House, a men’s recovery center dedicated to helping individuals overcome addiction and rebuild their lives. The Blake House provides a safe and structured environment for men working through recovery, offering guidance, accountability, and a path toward long-term sobriety. Recognizing the importance of maintaining a secure and stable facility, Perimeter Roofing stepped in t...

ST. PAUL, Minn.--(BUSINESS WIRE)--Accanto Health, the parent company of The Emily Program, announced the appointment of Jay Campbell as Chief Executive Officer....

TORONTO & LEESBURG, Fla.--(BUSINESS WIRE)--Greenspace Health and LifeStream Behavioral Center, a leading nonprofit provider of behavioral health and social services in Central Florida, have partnered to implement Measurement-Based Care (MBC) across LifeStream’s full continuum of programs. The collaboration will leverage data-driven insights and patient-reported outcome measures (PROMs) within the care process to improve service quality and clinical outcomes for thousands of individuals served a...

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Trilliant Health, the healthcare industry’s leading analytics and market research firm, today released its 2026 Behavioral Health Report, finding that the U.S. behavioral health crisis has intensified in the years following the COVID-19 pandemic. “The data in this report tell a story that is impossible to dismiss,” said Trilliant Health’s Chief Research Officer, Allison Oakes, Ph.D. “Behavioral health is not a peripheral concern, a niche service line or a prob...

DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) today announced the publication of a 56-week post hoc analysis of the effects of LYBALVI® (olanzapine and samidorphan) on negative symptoms in adults living with schizophrenia in the peer-reviewed publication The Journal of Clinical Psychiatry. The analysis—titled “The Efficacy of Olanzapine/Samidorphan on Negative Symptoms: A Post Hoc Analysis of 56-Week Treatment in Patients With Schizophrenia”—found that treatment with LYBALVI was associat...

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today an invitation for U.S. based organizations to apply for a grant to create training content for healthcare providers to deliver investigational COMP360 psilocybin treatment, if approved. Many high-quality training organizations already exist and have trained thousands of HCPs in core and psilocybin...

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company developing investigational therapies for patients with Alzheimer’s disease (AD) and related neurodegenerative disorders, today announced it will present new clinical, safety, imaging, and biomarker findings, as well as brain edema (ARIA-E) and brain microhemorrhage (ARIA-H) for its lead investigational therapy, valiltramiprosate/ALZ-801, at the American Academy of Neurology (AAN) Annual Meeting in Chic...

ATLANTA--(BUSINESS WIRE)--PTS has been named a USA TODAY Top Workplace, recognizing the company's commitment to building a supportive, hospitality-driven community....

HOUSTON--(BUSINESS WIRE)--Belmont Village Senior Living Leaders Honored with 2026 TALA Hero Award for Senior Care Excellence...